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Mutations in the transmembrane inner ear (Tmie) gene, which encodes the Tmie protein, have been
attributed to deafness autosomal recessive 6 (DFNB6), an autosomal nonsyndromic recessive hearing loss
disorder. Although the Tmie gene was identified a few years ago, little is known about subcellular
localization of the Tmie protein. In order to address this, we developed a stable cell line expressing Tmie
protein. The expression of Myc-tagged Tmie protein was confirmed by Western blot analysis using an
anti-Myc antibody and localization of the Tmie protein was confirmed by immunostaining, using the anti-
Myc antibody as well as the anti-tmie antibody. Our study demonstrates that the Tmie protein is localized
mostly in the cellular membrane and to a lesser extent in cytoplasm. These results suggest that our Tmie
expressing stable cell line provides a suitable in vitro model to explore Tmie synthesis and functions.
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Deafness is the most common form of sensory impairment
in humans. Over the last decade, enormous progress has
been made in the discovery of genes involved in hearing
and deafness, as well as in the identification of many new
loci and specific mutations that cause heritable deafness and
vestibular disorders [1]. There has been a particularly
tremendous escalation in the localization and identification
of genes for nonsyndromic hearing impairment. Inherited
deafness in humans is genetically heterogeneous, with effects
in any one of more than 100 distinct genes likely to be
responsible for nonsyndromic hearing loss [2]. The incidence
of hearing loss in humans is high, with a frequency of prelingual
deafness as high as 0.1-0.2% and a similar frequency of post-
lingual deafness before the third decade of life. Researchers
now believe that more than 60% of congenital deafness cases
in developed nations are caused by genetic factors [3]. Despite
difficulties in analysis of genetically heterogeneous conditions,
there has been dramatic progress in the localization and
identification of a large number of genes associated with
hearing loss during the past several years. The causes of
nonsyndromic deafness are complex. Researchers have
identified more than 30 genes that, when mutated, may cause
nonsyndromic deafness; however, some of these genes have
not been fully characterized.
Recently, loss-of-function mutations in the transmembrane
inner ear (Tmie) gene have been shown to cause deafness
in mice and humans [4-9]. These results indicate that the
Tmie gene has a critical role in the auditory system. Previously
our research group has reported that circling mice are a possible
animal model for deafness. These mice have a 40-kb genomic
deletion, including the Tmie gene [6,10-11].
In order to understand the subcellular localization and
functional relationships of the Tmie protein, we developed
a stable cell line for expressing Tmie protein. The cells (HEK293)
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were transfected with the Tmie expressing vector [pcDNA
3.1-Myc-His (5.5 Kb)-Tmie] and the expression of Myc-tagged
Tmie was confirmed by Western blot analysis and immuno-
staining analysis using anti-Myc and anti-Tmie antibodies. Our
results provide an excellent model for studying the synthesis
and localization of Tmie protein.
Materials and Methods
Construction of a Tmie expression vector
A Tmie expressing vector [pcDNA 3.1-Myc-His (5.5 Kb)-
Tmie] was used [12]. Briefly, mouse Tmie cDNA was amplified
by polymerase chain reaction (PCR) using the primer sets:
5’-CTGGACTCTCAGGACCTGCA-3’ and 5’-TCAGGAAGCC
GCCCTCATTT-3’. The amplified PCR product was ligated
into the XhoI and HindIII sites of mammalian expression system
vector pcDNA3.1-Myc-His (Invitrogen, Grand Island, NY, USA)
to yield the Tmie expression construct pcDNA 3.1-Tmie-Myc-
His. DNA sequencing was used to verify the nucleotide
sequences of the Tmie expression vector.
Construction of a stable cell line
The human embryonic kidney cell line (HEK293) was
obtained from the American type culture collection. HEK293
was maintained with Dulbecco’s modified Eagles medium
containing 10% fetal bovine serum, 25 mM HEPES, 100 U/
mL, penicillin and 100 µg/mL streptomycin. Cells were
cultured at 37
oC at 95% of air and 5% CO2 atmosphere.
To generate a stable cell line, we transfected 5 µg of the
Tmie expressing vector [pcDNA 3.1-Myc-His (5.5 Kb)-Tmie]
which confers neomycin resistance into HEK293 cells, using
FuGENE 6 transfection reagent (Roche, Mannheim, Germany)
according to manufacturer instruction, Two days after
transfection, cells were selected in 500 µg/mL G418 (Duchefa
Bioch, Haarlem, Netherlands) for 2 weeks.
Western blot analysis
Cells (5×10
6) were lysed in lysis buffer (50 mM Tris-HCl
pH7.4, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton
X-100, 1 mM PMSF). Clarified lysates were resolved on 12%
SDS-polyacrylamide gels and then transferred to polyvinylidene
fluoride transfer membranes (Millipore, Billerica, MA, USA).
The membranes were blocked in Tris-buffered saline containing
0.05% Tween 20 and 2% bovine serum albumin for 1 hr
at room temperature. Membranes were incubated with an
anti-Myc antibody (1:1,000, Cell Signaling Technology,
Danvers, MA, USA) for 2 h. Immunoreactive proteins were
detected using horseradish peroxidase-conjugated secondary
antibody (1:500, Jackson ImmunoResearch Laboratories, West
Grove, PA, USA) and enhanced Chemiluminescence reagent
(Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Immunofluorescence staining
For immunofluorescence staining, the stable cells were
cultured on glass coverslips in 12-well plates for 24 h in order
to detect Tmie localization. Cells were fixed with 4%
paraformaldehyde, permeabilized with 0.1% Triton X-100,
incubated with antibodies against Myc epitope (1:200), and
then incubated with Alexa Flour 633 conjugated goat anti-
mouse IgG (Molecular Probes, Grand Island, NY, USA). Nuclei
were stained with DAPI. Coverslips were mounted in
fluoromount-G (Southern Biotechnology Associates, Birmingham,
AL, USA). The mounted samples were scanned with an LSM
510 (Carl Zeiss, Jena, Germany). Several positive clones were
expanded and analyzed in this study.
Results
Stable expression of Myc-tagged Tmie in HEK 293
cells
Because we aimed to generate cell lines that stably express
Tmie, we transfected the vector containing Tmie and a
neomycin resistance gene (Figure 1). In order to monitor
expression of Tmie, we introduced a Myc epitope into the
end of Tmie gene. The vector sequences were confirmed
by an automatic sequencer. Thereafter HEK 293 cells were
selected with G418 for stable expression of the transgenes.
The Tmie protein expression level of the established cell lines
was determined by western blotting analysis as described
in methods. The Tmie expression level in the established
cell lines was monitored through several passages by Western
blot analysis. Stable transgene expression was observed with
different levels (Figure 2). No band was detected in
untransfected (empty vector) cells.
Subcellular localization of Myc-tagged Tmie
Along with analyzing the expression levels, we also studied
the subcellular localization of Tmie in the established cell
lines. The subcellular localization of Myc-tagged Tmie was
studied by immunofluorescent staining followed by confocal
microscopy. Detailed subcellular localization analysis
performed with HEK293 cells clearly demonstrated that the
Myc-tagged Tmie is expressed predominantly in the plasma
membrane (Figure 3).
Discussion
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caused by mutations in gene encoding proteins responsible
for a variety of processes, including the maintenance of hair
cell structure, neuronal innervations, and trafficking. Recently,
a high-throughput detection method of the mutations
responsible for hearing loss was established [13]. It has been
found that Tmie is responsible for nonsyndromic hearing loss
in humans [7-9]. The Tmie protein has a signal peptide and
at least one transmembrane domain [5]. According to the
proposed structure of Tmie, the mature protein may be
localized in the plasma membrane and serve as a site of
interaction for other molecules through its highly charged
C-terminal domain. Several papers suggest that the Tmie
protein may require maturation of sensory cells as well as
the normal development of the maintenance of stereocilia
[5,14-16].
To examine the subcellular localization of the Tmie protein
we generated a cell line that expresses the Tmie protein.
The Tmie protein expression in HEK293-Tmie cells was
monitored by using immunostaining analysis and the
Figure 1. The map and sequences of the expressing vector containing the Tmie gene (pcDNA 3.1-Myc-His).
Figure 2. Tmie expression in Tmie-HEK293 cell lines. Tmie
(~21 kDa) expression was detected by western blotting using
an anti-Myc antibody. Lane 1: lysate from HEK293 cells
transfected expressing an empty vector, Lane 2: lysate from
HEK293 cells transfected expressing a vector containing the
Tmie gene.
Figure 3. Subcellular localization of Tmie in Tmie-expressing cells (Tmie-HEK293). Expression of the Tmie protein was detected in
the stable cell line by confocal microscopy. Tmie protein expression was found in the cellular membrane (red) and to a lesser extent
in cytoplasm. Upper panels are expressing vector-treated cells. Lower panels are mock-treated cells. Merge indicates merged
images of Myc (green) and Tmie (red) immunofluorescence. (Scale bar=20 µm).342 Sankarapandian Karuppasamy et al.
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localization was observed through confocal microscopy. From
this study we concluded that the Tmie protein is mostly present
in the cellular membrane, which suggests that Tmie protein
may play an important role in signal trafficking between the
cells or in signal transduction in the auditory system. Tmie
protein probably joins with other proteins while transducting
signals in the auditory system.
We predict that the Tmie protein may play an important
functional role in cell metabolism and signal transduction.
However, more specific study is needed to understand its
functional role in adjacent cells. It remains to be determined
what specific role Tmie plays in hair cell development and
specifically, what advantages its localization and membrane
association provide. However the data provided in this study
offer a solid foundation from which these questions can better
be addressed.
In summary, we established a Tmie-expressing cell line on
HEK 293 cells, and the expression of Tmie was confirmed
by both western blotting and confocal microscopy. Considering
the shortcomings involved in functional analysis of Tmie, our
method ensures stable and high expression of the protein,
thus providing an excellent model for further research into
its biological effects. Further examination of the impact of
Tmie and its protein will provide insight into the pathways
that are critical for normal maturation of sensory cell function.
Analysis of Tmie expression and localization will also help
to define the molecular mechanism of hearing loss in humans
with defects at the DFNB6 locus, and will provide a system
to investigate potential therapies that rescue sensory cells and
preserve auditory function.
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